Effect of gender on reporting of MMR adverse events in Saudi Arabia
EMHJ-Eastern Mediterranean Health Journal. 2003; 9 (1-2): 152-158
in English
| IMEMR
| ID: emr-158147
ABSTRACT
We evaluated the safety of a measles-mumps-rubella [MMR] immunization campaign for Saudi children [age range 6-13 years] and gender differences in reporting post-MMR adverse events. After vaccinations were administered, we monitored 160 schools for 14 days and 19 hospitals in the 8 cities under study for 10 weeks. Incidence rates were all MMR adverse events, 26.5/10,000 MMR vaccines [significantly higher in females than males]; Urabe strain aseptic meningitis, 1.0/295,000; fever, 40.2/10,000 [females] and 0.9/10,000 [males]; and parotitis, 5.4/10,000 [females] and 0.9/10,000 [males]. Combined MMR vaccine containing the Urabe mumps strain was safe for children aged 6-13 years. Gender differences regarding reactogenicity were evident and should be considered when designing future studies
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Metabolic Clearance Rate
/
Data Collection
/
Adverse Drug Reaction Reporting Systems
/
Sex Distribution
/
Immunization Programs
/
Drug Hypersensitivity
/
Fever
Limits:
Adolescent
/
Child
/
Female
/
Humans
/
Male
Language:
English
Journal:
East Mediterr Health J.
Year:
2003
Similar
MEDLINE
...
LILACS
LIS